Bladder cancer cell-derived EVs can deliver the lncRNA LNMAT2, which promotes lymphangiogenesis and LNM by recruiting hnRNPA2B1 and increasing the H3K4 trimethylation level in the prospero homeobox 1 (PROX1) promoter (63). Here, PROX1 is linked to urinary bladder carcinoma.